You are viewing the site in preview mode
Skip to main content
| |
BMJ
|
Lancet
|
NEJM
|
JAMA
|
ANNALS
|
Total
|
|---|
|
Editorials
|
261
| |
3504
| |
124
| |
102
| |
39
| |
876
| |
|
UK
|
160
|
61.4%
|
167
|
47.7%
|
10
|
8.0%
|
02
|
1.9%
|
01
|
2.4%
|
340
|
38.8%
|
|
USA
|
38
|
14.6%
|
87
|
24.9%
|
97
|
78.3%
|
97
|
95.0%
|
35
|
90.0%
|
354
|
40.4%
|
|
OEAC1
|
56
|
21.4%
|
89
|
25.4%
|
14
|
11.3%
|
02
|
1.9%
|
03
|
7.6%
|
164
|
18.7%
|
|
RoW2
|
07
|
2.6%
|
07
|
2.0 %
|
03
|
2.4%
|
01
|
0.9%
|
00
|
0.0%
|
18
|
2.6%
|
|
Original papers
|
322
| |
307
| |
218
| |
227
| |
115
| |
1189
| |
|
UK
|
216
|
67.0%
|
66
|
21.5 %
|
06
|
2.7%
|
04
|
1.8%
|
03
|
2.6%
|
295
|
24.8%
|
|
USA
|
22
|
7.0%
|
38
|
12.4%
|
107
|
49.1%
|
173
|
76.2%
|
81
|
70.4%
|
421
|
35.4%
|
|
OEAC
|
76
|
23.6%
|
136
|
44.3 %
|
78
|
35.8%
|
42
|
18.5%
|
23
|
20.0%
|
355
|
29.9%
|
|
RoW
|
08
|
2.4%
|
67
|
21.8%
|
27
|
12.4%
|
08
|
3.5%
|
08
|
7.0%
|
118
|
9.9%
|
|
Correspondence
|
1118
| |
10435
| |
894
| |
605
| |
251
| |
3911
| |
|
UK
|
829
|
74%
|
374
|
35.8%
|
30
|
3.4%
|
13
|
2.1%
|
04
|
1.6%
|
1250
|
32%
|
|
USA
|
69
|
6%
|
141
|
13.5%
|
601
|
67.2%
|
506
|
83.6%
|
183
|
72.9%
|
1500
|
38.4%
|
|
OEAC
|
174
|
16%
|
400
|
38.3%
|
212
|
23.7%
|
71
|
11.7%
|
49
|
19.5%
|
906
|
23.2%
|
|
RoW
|
46
|
4%
|
128
|
12.2%
|
51
|
5.7%
|
15
|
2.5%
|
15
|
6.0%
|
255
|
6.5%
|
|
Review articles
|
286
| |
50
| |
65
| |
36
| |
66
| |
503
| |
|
UK
|
195
|
68.2%
|
17
|
34%
|
04
|
6.2%
|
01
|
2.7%
|
01
|
1.6%
|
218
|
43.3%
|
|
USA
|
29
|
10.2%
|
15
|
30%
|
48
|
73.8%
|
28
|
78.0%
|
61
|
92.4%
|
181
|
36%
|
|
OEAC
|
54
|
18.8%
|
14
|
28%
|
13
|
20.0%
|
04
|
11.1%
|
04
|
6.0%
|
89
|
17.7%
|
|
RoW
|
08
|
2.8%
|
04
|
08%
|
00
|
0.0%
|
03
|
8.2%
|
00
|
0.0%
|
15
|
3%
|
|
Others3
|
47
| |
208
| |
149
| |
145
| |
27
| |
576
| |
|
UK
|
31
|
66.0%
|
68
|
32.8%
|
03
|
02.0%
|
00
|
00.0%
|
00
|
00.0%
|
102
|
17.7%
|
|
USA
|
08
|
17.0%
|
34
|
16.3%
|
118
|
79.3%
|
120
|
82.7%
|
25
|
92.6%
|
305
|
53%
|
|
OEAC
|
04
|
8.5%
|
78
|
37.5%
|
22
|
14.7 %
|
16
|
11.0%
|
01
|
3.7%
|
121
|
21%
|
|
RoW
|
04
|
8.5%
|
28
|
13.4%
|
06
|
4.0%
|
09
|
6.2%
|
01
|
3.7%
|
48
|
8.3%
|
|
Global total
|
2034
| |
1958
| |
1450
| |
1115
| |
498
| |
7055
| |
|
RoW total
|
73
|
3.6%
|
234
|
12%
|
87
|
6%
|
36
|
3.2%
|
24
|
4.8%
|
454
|
6.4 %
|
- 1. OEAC (Other Euro-American countries), OEAC were European countries other than the UK, Australia, New Zealand and Canada.
- 2. RoW comprised all other countries (i.e. all countries in Eastern Europe, Central and South America, Asia and Africa)
- 3. Others include: for The Lancet: case reports, view points, public letters, essays, public health, violence in health, department of medical history, the world, world ideas, health and human rights, development of ethics, eponymous, clinical picture, reportage, adverse drug reactions, personal papers, medicine and law, personal papers; for the JAMA: Patients relationships, grand rounds, clinical cross roads, rational clinical examinations, medicine and media, commentary, updates, letters from counters, public opinion and health, medical literature, health law and ethics, clinical cross roads; for the NEJM: images, clinical problem solving, case records from Massachusetts general hospital, clinical implications of basic research, sounding board, clinical problem solving, special articles, for the BMJ: drug point, practice and results, quality of life, history, practice point, lessons of every week; for the Annals: past present and future, time and medicine, social means of medicine, technology of time, personal time, media and publication, NIH conference, in the balance, abroad.
- 4. The Lancet had 52 editorials and 298 commentaries. Editorials were written in house.
- 5. The Lancet had 262 research letters. We did not include these either in the correspondence or with the Original papers category. Other journals did not have such a category to compare.